One of the goals of islet transplantation is to transplant viable islets without host immunosuppression. The present study was designed to determine whether pretreatment of islets with mitomycin-C (MMC) followed by culture enhances islet survival in a rat-to-mouse xenogeneic combination. WS(RT1k) rat islets pretreated with various concentrations of MMC (0, 3.2, 10, 32, 100, 320, and 1000 µg/ml) were tested for viability by in vitro insulin secretory capacity and vital staining of islets. The MMC-treated islets (10 µg/ml) cultured for various periods (4, 20, or 40 h, 3 or 7 days) were transplanted into the renal subcapsular space of STZinduced diabetic C57BL/6 (B6: H-2b) mice. MMC-treated or nontreated islets were subjected to microarray gene analysis and immunohistological study. Evaluation of in vitro insulin secretory capacity and vital staining of islets indicated that MMC at a dose ≤32 µg/ml is nontoxic and preserves islet function. Marked prolongation of graft survival was noted with half of islet grafts surviving indefinitely (>100 days) when 10 µg/ml of MMC-treated islets was transplanted after 40 h or 3 days in culture, but not when they were transplanted within 4 h following treatment or at 7 days following treatment, indicating that there is a critical culture period necessary for successful islet graft survival. Microarray analysis suggested possible genes for this prolongation with TGF-β highly expressed in MMC-treated islets subjected to culture for 3 days. Our results indicate that MMC treatment followed by a critical culture period induces marked prolongation of rat islet xenograft survival in nonimmunosuppressed recipient mice, offering a strategy for islet transplantation without immunosuppression.
INTRODUCTION
failure is small when islet autografts were carried out in patients who had undergone a total pancreatectomy for pain caused by chronic pancreatitis (19) . Since the Edmonton group's successful report on human islet transplantation, in which seven consecutive An important step to encourage the use of this treatment modality widely used for the cure of diabetes is to patients quickly attained sustained insulin independence after transplantation (22) , more than 471 patients have transplant islets without immunosuppression. We have shown that the treatment of islets with mitomycin-C received islets at 43 institutions worldwide in the past 5 years (21) . High rates of insulin independence have been (MMC) and overnight culture before transplantation induces significant prolongation of graft survival in an is-observed at a 1 year follow-up at the leading centers (21) . However, insulin independence was lost in the ma-let allotransplantation (BALB/c to B6) (17) and xenotransplantation (rat to mouse) (8) model, and that the jority of recipients by 5 years (21) , and the side effects of immunosuppressants necessitate stringent inclusion effect of MMC treatment is concentration dependent. Thus, 3.2-32 µg/ml of MMC can potentially prolong criteria for islet-alone candidates. To improve outcome, antirejection drugs have been used based on their re-graft survival, although higher concentrations were toxic with regard to glucose regulation in vivo (8, 17) . In the duced toxicity to islets when compared to steroids, but they still harm the cells (2). Another possible result fol-allograft model, half of grafts survived indefinitely with low-grade antigen-specific unresponsiveness (17). In the lowing human islet transplantation includes rejection or recurrence of autoimmune diabetes. These possibilities xenograft model, prolongation was significant, but was limited with no indefinite survival (8). are reasonably assumed because the rate of late graft 620 GUNJI ET AL.
For clinical application, some modification of the Assessment of Cell Viability of MMC-Treated Islets above protocol is necessary. Here, we show that MMC The viability of MMC-treated islet cells was assessed treatment followed by 3-day culture of islets at 37°C by simultaneous use of the inclusion and exclusion dyes results in indefinite survival of islet xenografts in 50% acridine orange (AO) and propidium iodide (PI), as deof recipients, whereas culture alone was less effective.
scribed previously (1). Briefly, 10 to 50 islets were Together with these results, we identified potential genes stained for 10 min with 0.67 µM AO and 75 µM PI in responsible for prolongation of graft survival based on a phosphate-buffered saline (PBS). Then islets were exmicroarray gene expression profile study. Among these amined under confocal microscopy (model FV300, genes, TGF-β expression was demonstrated to be upreg-Olympus, Japan). Fluorescent images were obtained unulated histologically in these islets.
der a fluorescent microscope (Eclipse E800, Nikon, Japan) and a confocal laser microscope (FV300, Olympus, MATERIALS AND METHODS Japan). We used a fluorescent illuminator consisting of a 100-W mercurial light source with a 490-nm excitation Animals filter and a 510-nm barrier filter. This filter combination Seven-to 8-week-old male WS (RT1k) rats (WS rats, permits simultaneous visualization of the green emission Shionogi Pharmaceutical Co., Aburabi, Shiga, Japan) of AO, and the red emission of PI. Digital images of the were used as islet donors. Diabetes was induced in 6-to islets treated with various concentrations of MMC (0, 9-week-old male C57BL/6 (B6: H-2b) mice (Nihon Clea 3.2, 10, 32, 100, 320, and 1000 µg/ml) were analyzed Inc., Shizuoka, Japan) by IP injection of streptozotocin for AO-or PI-positive areas using Adobe Photoshop TM (250 mg/kg Sigma, Japan) under anesthesia with ether 3.0J and NIH-Image software (Version 1.61/fat). inhalation. Recipients were mice with nonfasting blood glucose levels over 400 mg/dl for 2 consecutive days Glucose-Stimulated Insulin Secretion before transplantation. The experimental protocol was Insulin secretory capacities to low (3.3 mM) and high approved by the Ethics Review Committee for Animal (20 mM) glucose were evaluated for the islets treated Experimentation of Fukushima Medical University, and with various concentrations of MMC (0, 3.2, 10, 32, all procedures in this experiment were performed ac-100, 320, and 1000 µg/ml, five measurements for each cording to the guidelines of the National Research concentration) and cultured for 20 h or for 3 days ac-Council's Guide for the Care and Use of Laboratory cording to the method described in a manual of clinical Animals.
islet transplantation in Japan (23). Briefly, 10 islets, each measuring 150 µm in diameter, handpicked from the pe-Islet Isolation, MMC Treatment, and Transplantation tri dish, were placed in a 12-well transwell microplate The islets were isolated using a protocol similar to (Corning Transwell 3403, pore size 12 µm) with 3.3 that reported previously (6). Briefly, we injected 3.0 ml mM glucose RPMI-1640 and 0.1% FCS at 37°C for 60 of Hank's balanced salt solution (Nissui, Tokyo, Japan) min under 5% CO 2 and 95% air for stabilization. After containing 2 mg/ml collagenase (collagenase S-1, Nitta preincubation, the transwell was placed in a second well Gelatin, Japan) into the common bile duct. The discluster containing 3.3 mM glucose RPMI-1640 and tended pancreas was removed and incubated at 37°C for 0.1% FCS and incubated at 37°C for 60 min. Then, the 35 min. Collagenase-digested islets were purified by transwell was placed in a third well cluster containing centrifugation on gradients composed of three different 20 mM glucose. Insulin content in the media of the sec-Ficoll (type 400, Sigma Chemical Co., St. Louis, MO) ond and third well clusters was measured for insulin densities (1.120, 1.090, and 1.050). After centrifugation, secretion in response to low and high glucose loads. the distinct layer of islets was collected and washed.
Stimulation index was calculated by dividing insulin se-These islets containing immunogenic contaminants cretion at high glucose by one at low glucose. (crude islets) were incubated for 30 min with MMC Extension of Culture Period of MMC-Treated Islets (Kyowa Hakko Kogyo, Tokyo, Japan) at different doses and Transplantation (0, 3.2, 10, 32, 100, 320, and 1000 µg/ml). The islets were then washed three times with RPMI-1640 contain-In our previous reports, the effect of MMC treatment was tested after overnight (20 h) culture following ing 2% fetal bovine serum (FBS) and cultured in complete medium [RPMI-1640 with HEPES (10 mM), L-MMC treatment (8). To determine the optimal culture period for maximum graft survival of MMC-treated (10 glutamine (2 mM), penicillin (100 U/ml), streptomycin sulfate (100 µg/ml), and 10% fetal calf serum] for 20 h µg/ml) islets, the culture period following MMC treatment was either 4, 20, 40 h, 3 or 7 days. Three to 400 at 37°C under 5% CO 2 /95% air in a humidified atmosphere. The islets were handpicked and their viability MMC-treated or untreated (only cultured for 20 h) crude-digested islets were transplanted into the renal was assessed by the following in vitro assay. subcapsular space of STZ-induced diabetic B6 mice as gene related to oncogenes and tumor suppressors, cellular signaling, apoptosis, and transcription regulators, at described previously (6). Rejection was defined as a blood glucose level higher than 300 mg/dl in two con-50°C for 16 h. The microarrays were washed according to the instructions provided by the manufacturer and the secutive measurements.
slides were air-blown dried, prepared for scanning, and Histology and Immunohistochemistry of Islet Graft scanned for fluorescence with GenePrix (Axon Instruments, Union City, CA). The intensity ratios were nor-The long-term functioning (>100 days) islet grafts were removed to examine whether normoglycemia is malized by the median to compare ratios between arrays. maintained by grafted islets and also for immunohisto-Statistical Analysis logical study. In some of these animals untreated islets, Data were expressed as mean ± SD. Graft survival in which were only cultured for 20 h, were transplanted different experimental groups was compared using the into the right renal subcapsular space. Removed tissues Kaplan-Meier test. Ratios of PI-positive to AO-positive were fixed in 10% formalin, and then stained with hearea, and insulin secretion in different experimental groups matoxylin-eosin (H&E). For detection of insulin and were compared using unpaired Student's t-test. Values glucagon in the graft, the paraffin sections were stained of p < 0.05 were considered statistically significant. All using rabbit antibodies specific for insulin, glucagons, statistical calculations were performed using Statviewand a peroxidase-labeled biotin-avidin detection system J5.0 system software (SAS Institute Inc., Cary, NC). Histofine SAB-PO kit (Nichirei, Japan). For detection of somatostatin, goat polyclonal antibody specific for so-RESULTS matostatin (D-20:sc-7819) and peroxidase-conjugated Assessment of Cell Viability of MMC-Treated Islets rabbit anti-goat immunoglobulin (Wako:P0160) were by Vital Staining Using PI and AO used.
To examine TGF-β expression in MMC-treated and PI-positive cells showing loss of membrane integrity cultured islets, islets cultured for 3 days were fixed in were found in the central area of islets significantly 4% paraformaldehyde at 4°C for 4 h, and embedded in more often when the MMC concentration was greater paraffin. A set of four serial sections (thickness 3 µm) than 100 µg/ml (Fig. 1 ). These cells also increased in was cut from each paraffin block, stained with mouse number with greater concentrations of MMC, and most anti-human TGF-β1, -β2, and -β3 monoclonal antibodcells within the islets were PI positive at a MMC conies (Genzyme Techne, CA), and biotin-conjugated goat centration of 1 mg/ml. These results suggest that MMC affinity-purified antibody to mouse IgG (Santa Cruz concentrations of ≤32 µg/ml are not toxic to the islets Biotechnology, Santa Cruz, CA) were used. To compare under membrane integrity examination. the level of active TGF-β staining in the graft between Assessment of Cell Viability of MMC-Treated Islets two groups, quantification was blindly performed using Based on In Vitro Insulin Secretion the following semiquantitative scoring system: grade 0-no positive cells; grade 1-few positive cells; grade Significant increase of insulin secretory response to 2-more than few but <10% of cells show intense stainhigh glucose as compared to low glucose was observed ing; grade 3-10% to 50% of cells show intense stainwhen the MMC concentration was ≤100 µg/ml ( Fig. 2a ). ing; grade 4->50% of cells show intense staining for
The stimulation index of MMC-treated islets was main-TGF-β.
tained when the MMC concentration was ≤32 µg/ml (Fig. 2b) , but the index decreased significantly when the Microarray Gene Expression Study MMC concentration was ≥100 µg/ml. These results indi-Islets isolated from 10 rats were pooled together and cate that MMC concentrations ≤32 µg/ml are not toxic divided into two groups. One islet group was treated to the islets based on insulin secretory capacity in rewith MMC at 10 µg/ml for 30 min while the other group sponse to glucose. was treated in a similar fashion without MMC and cul-Effect of Duration of Culture of MMC-Treated Islets tured for 20 h or 72 h.
on Survival Time Total RNA was purified with the Micro RNA Isolation Kit (Stratagene, San Diego, CA) according to the We compared the graft survival time of MMC-treated and untreated islets cultured for 4, 20, and 40 h, and 3 instructions supplied by the manufacturer. Total RNA (20 µg) was labeled with Cy3 fluorescent dye using the and 7 days. Although the mean graft survival time of MMC-treated and untreated islets that were cultured for Atras Fluorescent Labeling Kit (Clontech, Palo Alto, CA). Cy3-labeled probes were hybridized to rat Atras 4 h was not different (9.0 ± 0.4 vs. 9.3 ± 0.9 days), significant prolongation of graft survival was demonstrated Grass microarray 1.0 (Clontech), which includes 1091 genes with various functional categories, such as the when the culture period was extended up to 3 days (20 h: 33.8 ± 7.4 vs. 11.9 ± 0.8, p < 0.001; 40 h: 64.7 ± 10.4 within a few days both in animals given MMC-treated and untreated islets, suggesting that MMC treatment had vs. 24.8 ± 4.7, p < 0.002; 3 days: 65.4 ± 12.4 vs. 15.7 ± 2.3, p < 0.002) ( Fig. 3) . Maximum prolongation was no adverse effect on glucose metabolism. noted in mice transplanted with 3-day cultured MMC-Histology and Immunohistochemistry of Long-Term treated islets, with indefinite survival of 50% (>100 Functioning Islet Graft days) of islet xenografts. No significant prolongation effect was noted after 7-day culture (31.5 ± 9.2 vs. 22.6 ±
The animals bearing long-term functioning islet xenografts over 100 days became hyperglycemic following 6.3). The stimulation index of MMC-treated islets that were cultured for 3 days decreased to 2.5 ± 0.53, but graftectomy, indicating that normoglycemia was maintained by grafted islets. Immunohistological study dem-was better than that of untreated islets (1.7 ± 0.4). Normal nonfasting blood glucose levels were restored onstrated that long-term functioning islet grafts contained insulin, glucagons, and somatostatin with minimal inflam-similar to that of islets in culture alone when the values were plotted in relation to the expression value of the matory cell infiltration (Fig. 4) . The secondary grafts from the original donor strain were rejected on days 15, cultured alone islets (Fig. 5a ). Upregulation (FC >2) and downregulation (FC <0.5) of gene expression was de-37, and 42, respectively, which was somewhat delayed when compared to controls (11.9 ± 0.8 days). tected in 9 and 16 genes, while most of the remaining 1067 genes among 1091 were within the values of 0.5 < Microarray Gene Expression Profile After 3-Day FC < 2.0. On the other hand, prolongation of the culture Culture of MMC-Treated Islets period to 3 days induced various changes in gene expression, which included the upregulated expression of We compared the gene expression profile of MMCtreated and untreated islets cultured for 20 h and 3 days 442 genes and the downregulated expression of 158 genes with 490 genes within the value of 0.5 < FC < 2.0 following MMC treatment. The genes expressed in MMC-treated islets followed by 20-h culture were com- (Fig. 5b) . Similarly, MMC treatment followed by 3-day culture resulted in upregulated expression of 236 genes pared to those of islets in culture alone. The fold change (FC) in gene expression of MMC-treated islets was quite and downregulated expression of 155 genes with 699 genes being within the value of 0.5 < FC < 2.0 ( Fig. 5c ), lets was associated with production of TGF-β protein within the islets, we analyzed TGF-β protein expression suggesting that MMC treatment tended to downregulate the expression of many genes.
in MMC-treated islets (Fig. 6) . Although vital staining of islets in both groups showed relatively compact To determine the MMC-treatment associated gene expression profile rather than culture related effect, we shapes with some islets having PI-positive areas in the center, the process of fixing and embedding in paraffin compared the gene expression of MMC-treated and nontreated islets in culture for 3 days (Fig. 5d ). Twenty-five affected the vulnerability of nontreated islets, compared to MMC-treated islets. TGF-β was expressed strongly in upregulated genes (FC >5) were found in MMC-treated islets, with an expression value of >100 (Table 1) . Fur-peripheral areas of MMC-treated islets (grade 4) compared with those of nontreated islets (grade 3). thermore, three downregulated (FC <0.2) genes were identified in cultured islets with an expression value of DISCUSSION >100 (Table 1) . Among upregulated genes, TGF-β, as
We previously reported that crude digested islets prewell as type II activin receptor, which binds TGF-β sutreated with MMC prolonged graft survival time in a perfamily, were both highly upregulated following MMC xenogeneic rat-to-mouse model when they were cultured treatment compared to culture alone.
at 37°C for 20 h (8). While the difference was signifi-
TGF-β Protein Expression of MMC-Treated and 3-Day
cant, all xenografts eventually showed signs of rejection Cultured Islets within 35 days. In this study, we extended the culture period up to 7 days. Marked prolongation of graft sur-To determine whether the strong upregulation of TGF-β mRNA expression detected in MMC-treated is-vival time was noted when MMC-treated islets were Figure 5 . Gene expression of MMC-treated islets followed by 20-h or 3-day culture. Expression levels of various genes in MMCtreated islets cultured for 20 h (a) or 3 days (b) and those of untreated islets cultured for 3 days (c) were compared to those in untreated islets cultured for 20 h. Gene expression of MMC-treated and nontreated islets in culture for 3 days were compared between the two groups (d). Data are fold changes at 5, 1, or 0.2. (15) , specific mono-MMC treatment. Half of rat islet grafts survived indefinitely in B6 recipient mice with chemically induced dia-clonal antibodies such as anti-Ia (4), anti-dendritic cells (5), and anti-ICAM-1 molecules (7). However, it has betes. Although culture alone induced some prolongation of graft survival, the grafts were all eventually been difficult to produce indefinite survival of xenoislets without host immunosuppression except in one report by rejected.
Various modalities have been used to immunomodu-Hardy et al. (9), who showed that UV-irradiated Lew islet xenografts could survive indefinitely in B10.BR re-days postgrafting, whereas no adverse effect was found in mice bearing long-term functioning isografts regard-cipient mice. However, this was not the case when the same islets were grafted into Balb/C mice, which even-less of the dose of MMC (3.2, 10, 32, 100 µg/ml) (17).
To consider the application of this treatment for hu-tually rejected them before 90 days postgrafting. In most of these experiments as well as those reported by Hardy man patients, it is necessary to evaluate the effect of MMC treatment on islets prior to transplantation. In this et al., handpicked islets were used, which are less immunogenic compared to crude-digested islets that contain study, we examined islet viability by vital staining of islets and insulin secretory capacity in response to glu-highly immunogenic contaminants. In the present study, we used crude-digested islets to test the feasibility of a cose and compared those data with previous in vivo findings. Vital staining using AO and PI demonstrated treatment modality for preclinical islet transplantation.
We investigated the appropriate dose of MMC neces-that MMC at doses <32 µg/ml appeared to be nontoxic without increasing the number of AO-positive cells. In-sary to induce graft prolongation but not islet toxicity. We reported that MMC at doses of 10, 32, 50 and 100 sulin secretory capacity in response to glucose, which is a gold standard test for islet function in vitro, showed µg/ml are effective for prolongation of graft survival, while glucose metabolism posttransplantation deterio-that the stimulation index was maintained when the MMC dose was <32 µg/ml. Both in vitro studies indi-rated when the dose exceeded 32 µg/ml in a rat-tomouse combination (8). In a mouse model, a significant cated that MMC treatment at a dose <32 µg/ml is nontoxic and preserves islet function at 20 h following adverse effect was detected in both isografts and allografts when the dose of MMC was >32 µg/ml at 3 to 5 MMC treatment. This finding correlates well with the Figure 6 . Vital staining and immunohistological study of MMC-treated and nontreated islets cultured for 3 days. MMC-treated (b, d) and nontreated islets (a, c) that were cultured for 3 days were stained by PI and AO (a, b), and were immunohisotologically studied using anti-TGF-β antibody (c, d). Vital staining of islets in both groups showed relatively compact shape with some islets having PI-positive areas in the center. TGF-β was expressed strongly in peripheral areas of MMC-treated islets as compared with those of nontreated islets.
previous results of an in vivo study (17), suggesting that effect was obtained within a specific culture period and was supported by microarray gene profile analysis. The these modalities could be applicable for testing viability after MMC treatment in human islet preparations.
results of these two manipulations were reproducible and may offer a strategy for the preclinical application Previous studies showed that culture alone did not induce indefinite survival of rat islets in mouse recipients of this protocol in human islet transplantation. even with a variety of modifications, including tempera-
